Soros Fund Management - ONCOGENEX PHARMACEUTICALS IN ownership

ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106. A total of 69 filers reported holding ONCOGENEX PHARMACEUTICALS IN in Q2 2014. The put-call ratio across all filers is 4.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
Soros Fund Management ownership history of ONCOGENEX PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2014$115,00030,8000.00%
Other shareholders

There were no reported owners of ONCOGENEX PHARMACEUTICALS IN in Q2 2014.

NameSharesValueWeighting ↓
View complete list of ONCOGENEX PHARMACEUTICALS IN shareholders